111 related articles for article (PubMed ID: 6208313)
1. Analysis of 17D yellow fever virus envelope protein epitopes using monoclonal antibodies.
Schlesinger JJ; Walsh EE; Brandriss MW
J Gen Virol; 1984 Oct; 65 ( Pt 10)():1637-44. PubMed ID: 6208313
[TBL] [Abstract][Full Text] [Related]
2. Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies.
Gould EA; Buckley A; Cammack N; Barrett AD; Clegg JC; Ishak R; Varma MG
J Gen Virol; 1985 Jul; 66 ( Pt 7)():1369-82. PubMed ID: 2410549
[TBL] [Abstract][Full Text] [Related]
3. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.
Brandriss MW; Schlesinger JJ; Walsh EE; Briselli M
J Gen Virol; 1986 Feb; 67 ( Pt 2)():229-34. PubMed ID: 3944585
[TBL] [Abstract][Full Text] [Related]
4. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48.
Schlesinger JJ; Brandriss MW; Walsh EE
J Immunol; 1985 Oct; 135(4):2805-9. PubMed ID: 4031501
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein.
Schlesinger JJ; Brandriss MW; Monath TP
Virology; 1983 Feb; 125(1):8-17. PubMed ID: 6187129
[TBL] [Abstract][Full Text] [Related]
6. Yellow fever virus envelope protein has two discrete type-specific neutralizing epitopes.
Ryman KD; Ledger TN; Weir RC; Schlesinger JJ; Barrett AD
J Gen Virol; 1997 Jun; 78 ( Pt 6)():1353-6. PubMed ID: 9191929
[TBL] [Abstract][Full Text] [Related]
7. Use of a monoclonal antibody specific for wild-type yellow fever virus to identify a wild-type antigenic variant in 17D vaccine pools.
Gould EA; Buckley A; Cane PA; Higgs S; Cammack N
J Gen Virol; 1989 Jul; 70 ( Pt 7)():1889-94. PubMed ID: 2472467
[TBL] [Abstract][Full Text] [Related]
8. Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis.
Schlesinger JJ; Chapman S
J Gen Virol; 1995 Jan; 76 ( Pt 1)():217-20. PubMed ID: 7844536
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of a purified fragment of 17D yellow fever envelope protein.
Brandriss MW; Schlesinger JJ; Walsh EE
J Infect Dis; 1990 Jun; 161(6):1134-9. PubMed ID: 1693159
[TBL] [Abstract][Full Text] [Related]
10. Identification of monoclonal antibodies that distinguish between 17D-204 and other strains of yellow fever virus.
Barrett AD; Mathews JH; Miller BR; Medlen AR; Ledger TN; Roehrig JT
J Gen Virol; 1990 Jan; 71 ( Pt 1)():13-8. PubMed ID: 1689367
[TBL] [Abstract][Full Text] [Related]
11. Examination of the envelope glycoprotein of yellow fever vaccine viruses with monoclonal antibodies.
Barrett AD; Pryde A; Medlen AR; Ledger TN; Whitby JE; Gibson CA; DeSilva M; Groves DJ; Langley DJ; Minor PD
Vaccine; 1989 Aug; 7(4):333-6. PubMed ID: 2479185
[TBL] [Abstract][Full Text] [Related]
12. Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants.
Daffis S; Kontermann RE; Korimbocus J; Zeller H; Klenk HD; Ter Meulen J
Virology; 2005 Jul; 337(2):262-72. PubMed ID: 15919103
[TBL] [Abstract][Full Text] [Related]
13. Differential dengue cross-reactive and neutralizing antibody responses in BALB/c and Swiss albino mice induced by immunization with flaviviral vaccines and by infection with homotypic dengue-2 virus strains.
Lim CS; Chua JJ; Wilkerson J; Chow VT
Viral Immunol; 2006; 19(1):33-41. PubMed ID: 16553548
[TBL] [Abstract][Full Text] [Related]
14. Topographical analysis of epitope relationships on the envelope glycoprotein of yellow fever 17D vaccine and the wild type Asibi parent virus.
Cammack N; Gould EA
Virology; 1986 Apr; 150(2):333-41. PubMed ID: 2421479
[TBL] [Abstract][Full Text] [Related]
15. Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain).
Lobigs M; Dalgarno L; Schlesinger JJ; Weir RC
Virology; 1987 Dec; 161(2):474-8. PubMed ID: 2446422
[TBL] [Abstract][Full Text] [Related]
16. Neutralization of yellow fever virus studied using monoclonal and polyclonal antibodies.
Buckley A; Gould EA
J Gen Virol; 1985 Dec; 66 ( Pt 12)():2523-31. PubMed ID: 2999305
[TBL] [Abstract][Full Text] [Related]
17. Structure-Function of the Yellow Fever Virus Envelope Protein: Analysis of Antibody Epitopes.
Davis EH; Barrett ADT
Viral Immunol; 2020; 33(1):12-21. PubMed ID: 31682201
[TBL] [Abstract][Full Text] [Related]
18. Yellow fever monoclonal antibodies: type-specific and cross-reactive determinants identified by immunofluorescence.
Monath TP; Schlesinger JJ; Brandriss MW; Cropp CB; Prange WC
Am J Trop Med Hyg; 1984 Jul; 33(4):695-8. PubMed ID: 6206738
[TBL] [Abstract][Full Text] [Related]
19. Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice.
Ryman KD; Ledger TN; Campbell GA; Watowich SJ; Barrett AD
Virology; 1998 Apr; 244(1):59-65. PubMed ID: 9581778
[TBL] [Abstract][Full Text] [Related]
20. Expression of foreign protein epitopes at the surface of recombinant yellow fever 17D viruses based on three-dimensional modeling of its envelope protein.
Bonaldo MC; Garratt RC; Freire MS; Galler R
Cell Biochem Biophys; 2006; 44(3):313-24. PubMed ID: 16679518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
